Cobimetinib (R-enantiomer),
(R)-XL518,
934660-94-3,
BSMCAPRUBJMWDF-QGZVFWFLSA-N,
SCHEMBL188704,
DTXSID70585319,
Cobimetinib(GDC-0973; XL518),
ZINC60325171,
AKOS030527016,
(R)-XL 518,
CS-1022,
RL05869,
NCGC00346455-01,
HY-13079,
FT-0675877,
W-6119,
[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2R)-piperidin-2-yl]azetidin-1-yl}methanone,
[3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl][3-hydroxy-3-[(2R)-2-piperidinyl]-1-azetidinyl]methanone,
1-({3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}carbonyl)-3-[(2R)-piperidin-2-yl]azetidin-3-ol,
GDC-0973 (R-enantiomer),
XL518,
A11441,
934660-93-2,